Principal Financial Group Inc 9 Meters Biopharma, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.26 - $0.64 $18,175 - $44,739	-69,905 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.52 - $1.0 $621 - $1,196	1,196 Added 1.74%	69,905 $42,000
Q4 2021 Feb 09, 2022	SELL	$0.85 - $1.33 $17,446 - $27,298	-20,525 Reduced 23.0%	68,709 $67,000
Q3 2021 Nov 09, 2021	BUY	$1.03 - $1.41 $5,536 - $7,578	5,375 Added 6.41%	89,234 $116,000
Q2 2021 Aug 10, 2021	BUY	$1.04 - $1.5 $87,213 - $125,788	83,859 New	83,859 $92,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.